Jaguar Animal Health, Inc. is a development-stage animal health company focused on developing and commercializing gastrointestinal products for companion and production animals. The Company�s pipeline of prescription drug product candidates includes Canalevia, species-specific formulations of crofelemer, Virend and species-specific formulations of NP-500. The Company�s non-prescription products comprises of Neonorm Calf and species-specific formulations of Neonorm. Canalevia is the lead prescription drug product candidate for the treatment of various forms of watery diarrhea in dogs. The Company develops Virend for the treatment of herpes virus in cats. Neonorm Calf is used to improve gut health and normalize stool formation in preweaned dairy calves with scours.